Pricing Log in Create free account

Conexeu Sciences Inc. (CNXU) vs Coya Therapeutics, Inc. (COYA)

Conexeu Sciences Inc. and Coya Therapeutics, Inc. are both Biotechnology companies. Conexeu Sciences Inc. and Coya Therapeutics, Inc. are of similar size ($65.9M and $65.4M). Conexeu Sciences Inc. has the higher net margin (0.00% vs −270.2%) and the higher return on invested capital (−234.6% vs −15,230.9%). Across the 12 metrics below, Conexeu Sciences Inc. leads on 7 and Coya Therapeutics, Inc. on 5.

Valuation

Metric CNXU COYA Biotechnology median
P/E n/m n/m 10.60
P/S n/m 8.69 9.40
P/B 10.47 1.61 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 4.92 9.02
Earnings yield (27.44%) (36.03%) (32.88%)
Free cash flow yield (17.32%) (25.51%) (23.13%)

Profitability

Metric CNXU COYA Biotechnology median
Gross margin — 100.00% 68.51%
Operating margin 0.00% (288.70%) 0.00%
Net margin 0.00% (270.22%) 0.00%
Free cash flow margin 0.00% (221.64%) 0.00%
Return on equity (458.40%) (60.54%) (51.96%)
Return on assets (354.37%) (53.66%) (46.06%)
Return on invested capital (234.60%) (15,230.92%) 0.00%

Growth

Metric CNXU COYA Biotechnology median
Revenue growth (TTM) — 108.35% 6.76%
EPS growth (last fiscal year) (342.80%) (29.59%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CNXU COYA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.31 13.40 4.97
Net debt to EBITDA 1.23 2.08 1.01

Dividend

Metric CNXU COYA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CNXU COYA Biotechnology median
Market cap 65.36m 65.92m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack